药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Pergolide
Lorvotuzumab mertansine
The metabolism of Bosutinib can be decreased when combined with Lorvotuzumab mertansine.
Pergolide
Letermovir
The metabolism of Bosutinib can be decreased when combined with Letermovir.
Pergolide
Fostamatinib
The metabolism of Bosutinib can be decreased when combined with Fostamatinib.
Pergolide
Saracatinib
The metabolism of Bosutinib can be decreased when combined with Saracatinib.
Pergolide
Bryostatin 1
The metabolism of Bosutinib can be decreased when combined with Bryostatin 1.
Pergolide
Elbasvir
The metabolism of Bosutinib can be decreased when combined with Elbasvir.
Pergolide
Tylvalosin
The metabolism of Bosutinib can be decreased when combined with Tylvalosin.
Pergolide
Tylosin
The metabolism of Bosutinib can be decreased when combined with Tylosin.
Pergolide
Tilmicosin
The metabolism of Bosutinib can be decreased when combined with Tilmicosin.
Pergolide
Tildipirosin
The metabolism of Bosutinib can be decreased when combined with Tildipirosin.
Pergolide
Selamectin
The metabolism of Bosutinib can be decreased when combined with Selamectin.
Pergolide
Oleandomycin
The metabolism of Bosutinib can be decreased when combined with Oleandomycin.
Pergolide
Eprinomectin
The metabolism of Bosutinib can be decreased when combined with Eprinomectin.
Pergolide
Doramectin
The metabolism of Bosutinib can be decreased when combined with Doramectin.
Pergolide
Carbomycin
The metabolism of Bosutinib can be decreased when combined with Carbomycin.
Pergolide
Peppermint oil
The metabolism of Bosutinib can be decreased when combined with Peppermint oil.
Pergolide
Kitasamycin
The metabolism of Bosutinib can be decreased when combined with Kitasamycin.
Pergolide
Solithromycin
The metabolism of Bosutinib can be decreased when combined with Solithromycin.
Pergolide
Efonidipine
The metabolism of Bosutinib can be decreased when combined with Efonidipine.
Pergolide
Tofisopam
The metabolism of Bosutinib can be decreased when combined with Tofisopam.